References (Patients)

  1. Cloderm Cream [package insert]. Bridgewater, NJ: Promius Pharma LLC; 2008.
  2. Habif TP. Atopic dermatitis. In: Habif TP, ed. Clinical Dermatology. 5th ed. St. Louis, MO: Mosby; 2010:154-180.
  3. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am. 2002;22:1-24.
  4. Mayo Clinic. Atopic dermatitis (eczema). Mayo Clinic website. http://www.mayoclinic.com/health/eczema/DS00986. Accessed June 7, 2011.
  5. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643-659.
  6. Mayo Clinic. Psoriasis. Mayo Clinic website. http://www.mayoclinic.com/health/psoriasis/DS00193/. Accessed June 7, 2011.
  7. Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol. 2005;53(1 suppl 1):s50-s58.
  8. National Psoriasis Foundation. Topical steroid potency chart. National Psoriasis Foundation website. http://www.psoriasis.org/Page.aspx?pid=469. Accessed June 7, 2011.
  9. Data on file. Bridgewater, NJ: Promius Pharma, LLC. 2011.
  10. Royal Society of Chemistry. ChemSpider. http://www.chemspider.com/. Accessed June 7, 2011.
  11. Goa KL. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs. 1988;36(Suppl 5):51-61.
  12. Siddiqui O, Roberts MS, Polack AE. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharm. 1989;17(4):405-424.
  13. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138(2):293-296.
  14. Bikowski J, Pillai R, Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol. 2006;5(2):125-130.
  15. Baeck M, Chemelle JA, Rasse C, Terreux R, Goossens A. C(16)-methyl corticosteroids are far less allergenic than the non-methylated molecules. Contact Dermatitis. 2011;64(6):305-312.
  16. Data on file. Study #CDC1303. Bridgewater, NJ: Promius Pharma, LLC; 2013.
  17. Data on file. Study #CDC1304. Bridgewater, NJ: Promius Pharma, LLC; 2013.
  18. Data on file. Bridgewater, NJ: Promius Pharma, LLC; 2011.
  19. Maibach HI. Adrenal suppression study on Cloderm. Data on File. Bridgewater, NJ: Promius Pharma, LLC.
  20. Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol. 2006;54(4):723-727.